Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$112K Buy
211
+154
+270% +$71.1K 0.06% 296
2026
Q1
$28K Sell
57
-12
-17% -$6.14K 0.02% 981
2025
Q4
$39K Sell
69
-406
-85% -$230K 0.02% 1003
2025
Q3
$245K Sell
475
-142
-23% -$62K 0.14% 144
2025
Q2
$194K Sell
617
-37
-6% -$11.1K 0.11% 199
2025
Q1
$200K Sell
654
-1
-0.2% -$336 0.13% 157
2024
Q4
$218K Buy
655
+56
+9% +$19K 0.14% 145
2024
Q3
$201K Sell
599
-35
-6% -$13.3K 0.13% 170
2024
Q2
$261K Buy
634
+9
+1% +$3.56K 0.17% 88
2024
Q1
$253K Sell
625
-282
-31% -$99.1K 0.16% 85
2023
Q4
$278K Buy
907
+17
+2% +$4.59K 0.19% 56
2023
Q3
$216K Sell
890
-179
-17% -$45.8K 0.16% 93
2023
Q2
$257K Buy
1,069
+843
+373% +$175K 0.2% 63
2023
Q1
$43K Sell
226
-679
-75% -$140K 0.04% 765
2022
Q4
$192K Buy
905
+25
+3% +$5K 0.16% 124
2022
Q3
$138K Buy
880
+429
+95% +$68.5K 0.12% 200
2022
Q2
$68K Sell
451
-10
-2% -$1.45K 0.05% 628
2022
Q1
$75K Sell
461
-97
-17% -$16K 0.05% 668
2021
Q4
$122K Buy
+558
New +$117K 0.17% 94

Other funds holding MEDP

Covestor's MEDP Position: Q2 2026 in Review

Covestor increased its Medpace (MEDP) stake by 270% in Q2 2026, buying an estimated $71.1K and bringing the position to 211 shares worth $112K. The position accounts for 0.06% of the portfolio, ranked #296.

Covestor first reported a position in MEDP in Q4 2021 and has held it in 19 quarters since. The position peaked at $278K in Q4 2023. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Covestor held 211 shares of Medpace worth $112K as of Q2 2026.
  • Covestor bought 154 Medpace shares in Q2 2026, an estimated $71.1K.
  • Medpace made up 0.06% of Covestor's portfolio in Q2 2026, its #296 holding.
  • Covestor first reported a position in Medpace in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Medpace position peaked at $278K in Q4 2023.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.